Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study

Objective To examine the relationship between habitual caffeinated beverage consumption and headache frequency, duration, and intensity in a prospective cohort of adults with episodic migraine. Background Caffeine is a commonly ascribed headache trigger in adults with migraine and clinicians may cou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Headache 2024-03, Vol.64 (3), p.299-305
Hauptverfasser: Mittleman, Maggie R., Mostofsky, Elizabeth, Vgontzas, Angeliki, Bertisch, Suzanne M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 305
container_issue 3
container_start_page 299
container_title Headache
container_volume 64
creator Mittleman, Maggie R.
Mostofsky, Elizabeth
Vgontzas, Angeliki
Bertisch, Suzanne M.
description Objective To examine the relationship between habitual caffeinated beverage consumption and headache frequency, duration, and intensity in a prospective cohort of adults with episodic migraine. Background Caffeine is a commonly ascribed headache trigger in adults with migraine and clinicians may counsel patients to avoid caffeinated beverages; however, few studies have examined this association. Methods From March 2016 to August 2017, 101 adults with physician‐confirmed episodic migraine completed baseline questionnaires, including information about caffeinated beverage consumption. For 6 weeks, they reported headache onset, duration, and pain intensity (scale 0–100) on twice‐daily electronic diaries. Ninety‐seven participants completed data collection. We examined associations between self‐reported habitual caffeinated beverage consumption at baseline and headache outcomes prospectively captured over the following 6 weeks, adjusting for age, sex, and oral contraceptive use. Results The adjusted mean headache days per month was similar among the 20 participants reporting no habitual intake (7.1 days, 95% confidence interval [CI] 5.1–9.2), the 65 participants reporting 1–2 servings/day (7.4 days, 95% CI 6.1–8.7), and the 12 participants reporting 3–4 servings/day (5.9 days, 95% CI 3.3–8.4). Similarly, mean headache duration (no servings/day: 8.6 h, 95% CI 3.8–13.3; 1–2 servings/day: 8.5 h, 95% CI 5.5–11.5; 3–4 servings/day: 8.8 h, 95% CI 2.3–14.9) and intensity (no servings/day: 43.8, 95% CI 37.0–50.5; 1–2 servings/day: 43.1, 95% CI 38.9–47.4; 3–4 servings/day: 46.5, 95% CI 37.8–55.3) did not differ across levels of caffeinated beverage intake, though estimates were imprecise. Conclusions We found no association between habitual caffeinated beverage intake and headache frequency, duration, or intensity. These data do not support a recommendation that patients with episodic migraine should avoid consuming caffeine. Further research is needed to understand whether deviating from usual caffeine intake may trigger migraine attacks. Plain Language Summary Some patients and doctors believe that caffeine causes migraine headaches. We studied 98 adults with migraine who reported how much caffeine they typically drink and tracked their headaches every day for six weeks, and we found that the number of caffeine drinks people drink daily was not linked to headache frequency, duration, or pain level. These results suggest that patients with episodic migraine do not hav
doi_str_mv 10.1111/head.14673
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2922951942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2922951942</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3163-1f171fa997834ff43caa183217b7480d4297115564c0c157bce9ffc025c1280f3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EotvChR-ALHFBSCke27EdbqvSskiVuMA5cpzxrqt8ETtd7b_HYQsHDsxlLo-emXmHkDfAriHXxwPa9hqk0uIZ2UDJVSEVsOdkwxjowmhpLshljA-MMakq9ZJcCCPAKK035LizTUiL7aiz3mMYbMKWNviIs90jdeMQl35KYRyoHVq6jrLugJHafhz21LZLlyI9hnSgOIU4tsHRPuxnGwb8RLd0msc4oUvhcZUdxjnRmJb29Iq88LaL-PqpX5Efd7ffb3bF_bcvX2-294UToEQBHjR4W1XaCOm9FM5aMIKDbvJZrJW80gBlqaRjDkrdOKy8d4yXDrhhXlyR92dvXuTngjHVfYgOu84OOC6x5hXnVQmV5Bl99w_6MC7zkLfLlDKqZEat1Icz5fJlcUZfT3Po7XyqgdXrO-o1o_r3OzL89km5ND22f9E_-WcAzsAxdHj6j6re3W4_n6W_AJpClVs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2968650862</pqid></control><display><type>article</type><title>Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Mittleman, Maggie R. ; Mostofsky, Elizabeth ; Vgontzas, Angeliki ; Bertisch, Suzanne M.</creator><creatorcontrib>Mittleman, Maggie R. ; Mostofsky, Elizabeth ; Vgontzas, Angeliki ; Bertisch, Suzanne M.</creatorcontrib><description>Objective To examine the relationship between habitual caffeinated beverage consumption and headache frequency, duration, and intensity in a prospective cohort of adults with episodic migraine. Background Caffeine is a commonly ascribed headache trigger in adults with migraine and clinicians may counsel patients to avoid caffeinated beverages; however, few studies have examined this association. Methods From March 2016 to August 2017, 101 adults with physician‐confirmed episodic migraine completed baseline questionnaires, including information about caffeinated beverage consumption. For 6 weeks, they reported headache onset, duration, and pain intensity (scale 0–100) on twice‐daily electronic diaries. Ninety‐seven participants completed data collection. We examined associations between self‐reported habitual caffeinated beverage consumption at baseline and headache outcomes prospectively captured over the following 6 weeks, adjusting for age, sex, and oral contraceptive use. Results The adjusted mean headache days per month was similar among the 20 participants reporting no habitual intake (7.1 days, 95% confidence interval [CI] 5.1–9.2), the 65 participants reporting 1–2 servings/day (7.4 days, 95% CI 6.1–8.7), and the 12 participants reporting 3–4 servings/day (5.9 days, 95% CI 3.3–8.4). Similarly, mean headache duration (no servings/day: 8.6 h, 95% CI 3.8–13.3; 1–2 servings/day: 8.5 h, 95% CI 5.5–11.5; 3–4 servings/day: 8.8 h, 95% CI 2.3–14.9) and intensity (no servings/day: 43.8, 95% CI 37.0–50.5; 1–2 servings/day: 43.1, 95% CI 38.9–47.4; 3–4 servings/day: 46.5, 95% CI 37.8–55.3) did not differ across levels of caffeinated beverage intake, though estimates were imprecise. Conclusions We found no association between habitual caffeinated beverage intake and headache frequency, duration, or intensity. These data do not support a recommendation that patients with episodic migraine should avoid consuming caffeine. Further research is needed to understand whether deviating from usual caffeine intake may trigger migraine attacks. Plain Language Summary Some patients and doctors believe that caffeine causes migraine headaches. We studied 98 adults with migraine who reported how much caffeine they typically drink and tracked their headaches every day for six weeks, and we found that the number of caffeine drinks people drink daily was not linked to headache frequency, duration, or pain level. These results suggest that patients with episodic migraine do not have to avoid drinks with caffeine.</description><identifier>ISSN: 0017-8748</identifier><identifier>EISSN: 1526-4610</identifier><identifier>DOI: 10.1111/head.14673</identifier><identifier>PMID: 38318677</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Adults ; Beverages ; Beverages - adverse effects ; Caffeine ; Caffeine - adverse effects ; cohort study ; Consumption ; Contraceptives ; Data collection ; Headache ; Headache - epidemiology ; headache trigger ; Headaches ; Humans ; Migraine ; Migraine Disorders ; Oral contraceptives ; Patients ; Prospective Studies</subject><ispartof>Headache, 2024-03, Vol.64 (3), p.299-305</ispartof><rights>2024 American Headache Society.</rights><rights>Copyright © 2024 American Headache Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3163-1f171fa997834ff43caa183217b7480d4297115564c0c157bce9ffc025c1280f3</cites><orcidid>0000-0002-5191-1475</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhead.14673$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhead.14673$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38318677$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mittleman, Maggie R.</creatorcontrib><creatorcontrib>Mostofsky, Elizabeth</creatorcontrib><creatorcontrib>Vgontzas, Angeliki</creatorcontrib><creatorcontrib>Bertisch, Suzanne M.</creatorcontrib><title>Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study</title><title>Headache</title><addtitle>Headache</addtitle><description>Objective To examine the relationship between habitual caffeinated beverage consumption and headache frequency, duration, and intensity in a prospective cohort of adults with episodic migraine. Background Caffeine is a commonly ascribed headache trigger in adults with migraine and clinicians may counsel patients to avoid caffeinated beverages; however, few studies have examined this association. Methods From March 2016 to August 2017, 101 adults with physician‐confirmed episodic migraine completed baseline questionnaires, including information about caffeinated beverage consumption. For 6 weeks, they reported headache onset, duration, and pain intensity (scale 0–100) on twice‐daily electronic diaries. Ninety‐seven participants completed data collection. We examined associations between self‐reported habitual caffeinated beverage consumption at baseline and headache outcomes prospectively captured over the following 6 weeks, adjusting for age, sex, and oral contraceptive use. Results The adjusted mean headache days per month was similar among the 20 participants reporting no habitual intake (7.1 days, 95% confidence interval [CI] 5.1–9.2), the 65 participants reporting 1–2 servings/day (7.4 days, 95% CI 6.1–8.7), and the 12 participants reporting 3–4 servings/day (5.9 days, 95% CI 3.3–8.4). Similarly, mean headache duration (no servings/day: 8.6 h, 95% CI 3.8–13.3; 1–2 servings/day: 8.5 h, 95% CI 5.5–11.5; 3–4 servings/day: 8.8 h, 95% CI 2.3–14.9) and intensity (no servings/day: 43.8, 95% CI 37.0–50.5; 1–2 servings/day: 43.1, 95% CI 38.9–47.4; 3–4 servings/day: 46.5, 95% CI 37.8–55.3) did not differ across levels of caffeinated beverage intake, though estimates were imprecise. Conclusions We found no association between habitual caffeinated beverage intake and headache frequency, duration, or intensity. These data do not support a recommendation that patients with episodic migraine should avoid consuming caffeine. Further research is needed to understand whether deviating from usual caffeine intake may trigger migraine attacks. Plain Language Summary Some patients and doctors believe that caffeine causes migraine headaches. We studied 98 adults with migraine who reported how much caffeine they typically drink and tracked their headaches every day for six weeks, and we found that the number of caffeine drinks people drink daily was not linked to headache frequency, duration, or pain level. These results suggest that patients with episodic migraine do not have to avoid drinks with caffeine.</description><subject>Adult</subject><subject>Adults</subject><subject>Beverages</subject><subject>Beverages - adverse effects</subject><subject>Caffeine</subject><subject>Caffeine - adverse effects</subject><subject>cohort study</subject><subject>Consumption</subject><subject>Contraceptives</subject><subject>Data collection</subject><subject>Headache</subject><subject>Headache - epidemiology</subject><subject>headache trigger</subject><subject>Headaches</subject><subject>Humans</subject><subject>Migraine</subject><subject>Migraine Disorders</subject><subject>Oral contraceptives</subject><subject>Patients</subject><subject>Prospective Studies</subject><issn>0017-8748</issn><issn>1526-4610</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhi0EotvChR-ALHFBSCke27EdbqvSskiVuMA5cpzxrqt8ETtd7b_HYQsHDsxlLo-emXmHkDfAriHXxwPa9hqk0uIZ2UDJVSEVsOdkwxjowmhpLshljA-MMakq9ZJcCCPAKK035LizTUiL7aiz3mMYbMKWNviIs90jdeMQl35KYRyoHVq6jrLugJHafhz21LZLlyI9hnSgOIU4tsHRPuxnGwb8RLd0msc4oUvhcZUdxjnRmJb29Iq88LaL-PqpX5Efd7ffb3bF_bcvX2-294UToEQBHjR4W1XaCOm9FM5aMIKDbvJZrJW80gBlqaRjDkrdOKy8d4yXDrhhXlyR92dvXuTngjHVfYgOu84OOC6x5hXnVQmV5Bl99w_6MC7zkLfLlDKqZEat1Icz5fJlcUZfT3Po7XyqgdXrO-o1o_r3OzL89km5ND22f9E_-WcAzsAxdHj6j6re3W4_n6W_AJpClVs</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Mittleman, Maggie R.</creator><creator>Mostofsky, Elizabeth</creator><creator>Vgontzas, Angeliki</creator><creator>Bertisch, Suzanne M.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5191-1475</orcidid></search><sort><creationdate>202403</creationdate><title>Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study</title><author>Mittleman, Maggie R. ; Mostofsky, Elizabeth ; Vgontzas, Angeliki ; Bertisch, Suzanne M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3163-1f171fa997834ff43caa183217b7480d4297115564c0c157bce9ffc025c1280f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Beverages</topic><topic>Beverages - adverse effects</topic><topic>Caffeine</topic><topic>Caffeine - adverse effects</topic><topic>cohort study</topic><topic>Consumption</topic><topic>Contraceptives</topic><topic>Data collection</topic><topic>Headache</topic><topic>Headache - epidemiology</topic><topic>headache trigger</topic><topic>Headaches</topic><topic>Humans</topic><topic>Migraine</topic><topic>Migraine Disorders</topic><topic>Oral contraceptives</topic><topic>Patients</topic><topic>Prospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mittleman, Maggie R.</creatorcontrib><creatorcontrib>Mostofsky, Elizabeth</creatorcontrib><creatorcontrib>Vgontzas, Angeliki</creatorcontrib><creatorcontrib>Bertisch, Suzanne M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Headache</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mittleman, Maggie R.</au><au>Mostofsky, Elizabeth</au><au>Vgontzas, Angeliki</au><au>Bertisch, Suzanne M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study</atitle><jtitle>Headache</jtitle><addtitle>Headache</addtitle><date>2024-03</date><risdate>2024</risdate><volume>64</volume><issue>3</issue><spage>299</spage><epage>305</epage><pages>299-305</pages><issn>0017-8748</issn><eissn>1526-4610</eissn><abstract>Objective To examine the relationship between habitual caffeinated beverage consumption and headache frequency, duration, and intensity in a prospective cohort of adults with episodic migraine. Background Caffeine is a commonly ascribed headache trigger in adults with migraine and clinicians may counsel patients to avoid caffeinated beverages; however, few studies have examined this association. Methods From March 2016 to August 2017, 101 adults with physician‐confirmed episodic migraine completed baseline questionnaires, including information about caffeinated beverage consumption. For 6 weeks, they reported headache onset, duration, and pain intensity (scale 0–100) on twice‐daily electronic diaries. Ninety‐seven participants completed data collection. We examined associations between self‐reported habitual caffeinated beverage consumption at baseline and headache outcomes prospectively captured over the following 6 weeks, adjusting for age, sex, and oral contraceptive use. Results The adjusted mean headache days per month was similar among the 20 participants reporting no habitual intake (7.1 days, 95% confidence interval [CI] 5.1–9.2), the 65 participants reporting 1–2 servings/day (7.4 days, 95% CI 6.1–8.7), and the 12 participants reporting 3–4 servings/day (5.9 days, 95% CI 3.3–8.4). Similarly, mean headache duration (no servings/day: 8.6 h, 95% CI 3.8–13.3; 1–2 servings/day: 8.5 h, 95% CI 5.5–11.5; 3–4 servings/day: 8.8 h, 95% CI 2.3–14.9) and intensity (no servings/day: 43.8, 95% CI 37.0–50.5; 1–2 servings/day: 43.1, 95% CI 38.9–47.4; 3–4 servings/day: 46.5, 95% CI 37.8–55.3) did not differ across levels of caffeinated beverage intake, though estimates were imprecise. Conclusions We found no association between habitual caffeinated beverage intake and headache frequency, duration, or intensity. These data do not support a recommendation that patients with episodic migraine should avoid consuming caffeine. Further research is needed to understand whether deviating from usual caffeine intake may trigger migraine attacks. Plain Language Summary Some patients and doctors believe that caffeine causes migraine headaches. We studied 98 adults with migraine who reported how much caffeine they typically drink and tracked their headaches every day for six weeks, and we found that the number of caffeine drinks people drink daily was not linked to headache frequency, duration, or pain level. These results suggest that patients with episodic migraine do not have to avoid drinks with caffeine.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38318677</pmid><doi>10.1111/head.14673</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-5191-1475</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0017-8748
ispartof Headache, 2024-03, Vol.64 (3), p.299-305
issn 0017-8748
1526-4610
language eng
recordid cdi_proquest_miscellaneous_2922951942
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects Adult
Adults
Beverages
Beverages - adverse effects
Caffeine
Caffeine - adverse effects
cohort study
Consumption
Contraceptives
Data collection
Headache
Headache - epidemiology
headache trigger
Headaches
Humans
Migraine
Migraine Disorders
Oral contraceptives
Patients
Prospective Studies
title Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T04%3A45%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Habitual%20caffeinated%20beverage%20consumption%20and%20headaches%20among%20adults%20with%20episodic%20migraine:%20A%20prospective%20cohort%20study&rft.jtitle=Headache&rft.au=Mittleman,%20Maggie%20R.&rft.date=2024-03&rft.volume=64&rft.issue=3&rft.spage=299&rft.epage=305&rft.pages=299-305&rft.issn=0017-8748&rft.eissn=1526-4610&rft_id=info:doi/10.1111/head.14673&rft_dat=%3Cproquest_cross%3E2922951942%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2968650862&rft_id=info:pmid/38318677&rfr_iscdi=true